Michiel Bak

MD | PhD candidate dept. Gastroenterology and Hepatology/Surgery Erasmus MC, Rotterdam, the Netherlands |
Research fellow at @SinaiHealth

[Dr Mark Silverberg @guthealthmd]

Yes diet matters in managing #crohnsdisease. We may not have all the answers yet nor for all patient scenarios. But have a read of our study by the @ibdgc where we identify specific micronutrients that are associated with recurrence after ileal resection surgery. Expertly analyzed and written by @MichielBak @karenjboland and now available @JCC_IBD
Micronutrients are associated with endoscopic postoperative recurrence in Crohn’s disease: a multicenter prospective cohort study in North america https://t.co/b89NzXsBTB

[Sun-Ho Lee, MD, PhD @SunHoLee15]

1/
Our new study at IBD Journal linking Isolated Anastomotic Ulcer (IAU) to long-term recurrence post-operatively and microbiome shifts.

@MichielBak @poliverasendra @TurpinWilliams @HaimLeiboIBD @guthealthmd @SinaiHealth
@AnthonydeBuck @mantaj_brar

https://t.co/WBfA6aLs7c

[Dr Mark Silverberg @guthealthmd]

Come hear @MichielBak - the wizard of post op CD - talk about nutrients associated with recurrence after surgery. #DDW2025 Tuesday at 315pm.

[Michiel Bak @MichielBak]

@AnthonydeBuck @mantaj_brar

[Michiel Bak @MichielBak]

Our paper is out in @Bioeng_MDPI!

Treatment with additional autologous injection of platelet-rich stroma for transsphincteric fistulas:
✅ 77% long-term primary fistula healing of which 94% radiological healing
✅ low recurrence rates up to 9%

https://t.co/0nH29ipyNM

[Michiel Bak @MichielBak]

Great start of the year with two accepted papers in @APandT & @IBDJournals focused on post-operative recurrence in Crohn's disease and perianal CD! Full-text out soon🙌

@guthealthmd @MatthieuAllez @AnthonydeBuck @SunHoLee15

[Michiel Bak @MichielBak]

Really happy & proud that the first results of the IMPACT consortium 🇳🇱🇨🇦🇺🇸🇫🇷 (International Multidisciplinary Research Collaboration on Postoperative IBD) have been accepted as digital oral presentation at ECCO '25.

Stay tuned for more! @guthealthmd @MatthieuAllez @Y_ECCO_IBD

[Michiel Bak @MichielBak]

@IldikoMe @guthealthmd

[Michiel Bak @MichielBak]

@AGA_Gastro @Siyan_Cao @guthealthmd

[Michiel Bak @MichielBak]

Happy for the opportunity to present our work on combined histopathological and clinical risk stratification in posteroperative recurrence in Crohn’s disease at the UEG Week 2024 @my_ueg

And honoured to have won the best abstract prize🙌

[Michiel Bak @MichielBak]

@guthealthmd @MatthieuAllez

[Michiel Bak @MichielBak]

📢No difference in interobserver agreement for endoscopic scores in postoperative recurrence in CD
👏Substantial agreement for lesions in neo-TI
👉Moderate agreement for anastomotic lesions

❗️Further improvement warranted as therapeutic decisions are based on endoscopic scores

[GIE @GIE_Journal]

Editor's Choice: Bak et al review "Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn’s disease." https://t.co/49HZaDc9Bi

#GITwitter #GIEJournal

@NEndoscopy

[Michiel Bak @MichielBak]

Our open-access systematic review on risk factors for postoperative endoscopic recurrence in Crohn's disease is now out in @APandT!

https://t.co/r4ktYMkBvE

@KarlijnDemers @MatthieuAllez @guthealthmd

[Michiel Bak @MichielBak]

@GIE_Journal
🧐Interobserver agreement endoscopic scores for post-op recurrence in CD

🔺substantial IOA modified & updated Rutgeerts' score and REMIND score (lesions neo-TI)

📣 improvement warranted as therapeutic decisions are based on these scores

https://t.co/43BmPkXuCn